Northern Trust
ODT

Northern Trust’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Northern Trust’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-54,472
Closed -$74K – 4868
2021
Q4 		$74K Buy
54,472
+8,128
+18% +$19.2K ﹤0.01% 4509
2021
Q3 		$135K Buy
46,344
+116
+0.3% +$386 ﹤0.01% 4322
2021
Q2 		$161K Sell
46,228
-141,648
-75% -$486K ﹤0.01% 4228
2021
Q1 		$643K Sell
187,876
-5,786
-3% -$109K ﹤0.01% 3741
2020
Q4 		$3.72M Buy
193,662
+29,585
+18% +$457K ﹤0.01% 2847
2020
Q3 		$2.2M Sell
164,077
-2,567
-2% -$72.7K ﹤0.01% 3019
2020
Q2 		$7.06M Buy
166,644
+31,771
+24% +$1.03M ﹤0.01% 2311
2020
Q1 		$3.72M Sell
134,873
-20,278
-13% -$591K ﹤0.01% 2475
2019
Q4 		$5.04M Sell
155,151
-4,548
-3% -$141K ﹤0.01% 2579
2019
Q3 		$4.16M Buy
159,699
+52,410
+49% +$1.75M ﹤0.01% 2657
2019
Q2 		$3.94M Buy
107,289
+3,305
+3% +$79.2K ﹤0.01% 2680
2019
Q1 		$2.3M Buy
103,984
+12,434
+14% +$217K ﹤0.01% 2988
2018
Q4 		$1.29M Buy
91,550
+9,125
+11% +$142K ﹤0.01% 3269
2018
Q3 		$1.6M Buy
82,425
+7,915
+11% +$161K ﹤0.01% 3318
2018
Q2 		$1.65M Buy
74,510
+4,204
+6% +$97.9K ﹤0.01% 3297
2018
Q1 		$1.49M Buy
+70,306
New +$1.66M ﹤0.01% 3249

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Northern Trust's ODT Position: Q1 2022 in Review

Northern Trust sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 54,472 shares — an estimated $74K sold.

Northern Trust first reported a position in ODT in Q1 2018 and held it in 16 quarters. The position peaked at $7.06M in Q2 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • Northern Trust reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Northern Trust sold 54,472 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $74K.
  • Northern Trust first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • Northern Trust's Odonate Therapeutics, Inc. Common Stock position peaked at $7.06M in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Northern Trust's 13F filing for Q1 2022, filed 13 May 2022.